3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
5
Lung Neoplasms
4
Colorectal Neoplasms
4
Prostatic Neoplasms
3
Multiple Myeloma
2
Lymphoma
2
Gastrointestinal Neoplasms
2
Support of the Family as a Caregiving System
1
Stomach Neoplasms
1
Sarcoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Otorhinolaryngologic Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Mixed Dementias
1
Meningeal Carcinomatosis
1
Malignant Female Reproductive System Neoplasm
1
Lymphoma, Follicular
1
Localized Head and Neck Carcinoma
1
Lewy Body Disease
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Disease
1
Dementia, Vascular
1
Dementia
1
Cognitive Dysfunction
1
Cigarette Smoking-Related Carcinoma
1
Cardiovascular Diseases
1
Interventions
Radiosurgery
51
Magnetic Resonance Spectroscopy
34
Temozolomide
28
pembrolizumab
24
Bevacizumab
24
Radiotherapy
20
Nivolumab
20
Specimen Handling
14
Ipilimumab
13
Cyclophosphamide
13
Mental Status and Dementia Tests
12
Carboplatin
12
abemaciclib
10
Radiation
10
Blood Specimen Collection
9
trastuzumab deruxtecan
8
Proton Therapy
7
Pemetrexed
7
Memantine
7
fluciclovine F-18
6
binimetinib
6
Paclitaxel
6
Lomustine
6
Etoposide
6
Cisplatin
6
Capecitabine
6
encorafenib
5
Trastuzumab
5
Surveys and Questionnaires
5
Surgical Procedures, Operative
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
Referral and Consultation
×
1 year
×
Clear all
NCT05404308
2025-09-17
MERMOSE
Centre Francois Baclesse
Phase NA
Active not recruiting
92 enrolled